Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data
Hidradenitis suppurativa (HS) is a relapsing, inflammatory disease characterized by painful nodules, abscesses, sinuses track formation and scarring. HS has a great impact on patients' quality of life and its treatment may be really challenging. Adalimumab provides a new therapeutic option for...
Saved in:
Main Authors: | Aikaterini Kyriakou (Author), Anastasia Trigoni (Author), Nikiforos Galanis (Author), Dimitrios Sotiriadis (Author), Aikaterini Patsatsi (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
by: Fotiadou C, et al.
Published: (2016) -
Adalimumab effect on pain in hidradenitis suppurativa patients: systematic review and meta-analysis
by: Aikaterini Tsentemeidou, et al.
Published: (2022) -
Adalimumab in the treatment of moderate-severe hidradenitis suppurativa: a cost-effectiveness analysis
by: Sofia Borges, et al.
Published: (2018) -
Linear atrophoderma of Moulin: a case report and review of the literature
by: Aikaterini Patsatsi, et al.
Published: (2013) -
Interstitial Granulomatous Dermatitis: Another Clinical Variant
by: Aikaterini Patsatsi, et al.
Published: (2011)